GO
| HSI1 | 24,498.95 | -18.81 | 236.41B |
| HSCEI1 | 8,853.10 | -8.29 | 74.68B |
| Back Zoom + Zoom - Block Traded | |
|
2025-07-17 10:16:15 Nomura has published a report initiating coverage on HENGRUI PHARMA (01276.HK)'s H-shares with a target price of HKD71.5 and a Neutral rating. The broker predicted HENGRUI PHARMA's revenue to grow by 13.3% and 11.5% YoY to RMB31.7 billion and RMB35.3 billion in FY25 and FY26, respectively. Its earnings for FY25 and FY26 are projected to increase by 25% and 19% YoY to RMB7.9 billion and RMB9.4 billion. ~ AAStocks Financial News Web Site: www.aastocks.com | |